Home/Filings/4/0001179110-13-015571
4//SEC Filing

Astex Pharmaceuticals, Inc 4

Accession 0001179110-13-015571

CIK 0000919722operating

Filed

Oct 15, 8:00 PM ET

Accepted

Oct 16, 7:33 PM ET

Size

10.8 KB

Accession

0001179110-13-015571

Insider Transaction Report

Form 4
Period: 2013-10-11
Transactions
  • Disposition to Issuer

    Director Stock Option (Right to buy)

    2013-10-1120,0000 total
    Exercise: $2.10Exp: 2022-06-22Common Stock (20,000 underlying)
  • Disposition to Issuer

    Director Stock Option (Right to buy)

    2013-10-1150,0000 total
    Exercise: $2.94Exp: 2021-07-20Common Stock (50,000 underlying)
Footnotes (6)
  • [F1]The option originally provided for vesting as to 20% of the shares on July 20, 2011 and each one year anniversary thereafter. Pursuant to the Agreement and Plan of Merger, dated September 5, 2013, between the Issuer, Otsuka Pharmaceutical Co., Ltd., and Autumn Acquisition Corporation (the "Merger Agreement"), the option vested in full immediately prior to the closing of the merger.
  • [F2]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $278,000.00, which represents the difference between $8.50 and the exercise price of the option per share.
  • [F3]The option provided for vesting as to 1/4th of the shares on June 22, 2012 and on each three month anniversary thereafter.
  • [F4]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $128,000.00, which represents the difference between $8.50 and the exercise price of the option per share.
  • [F5]The option originally provided for vesting as to 1/4th of the shares on June 13, 2013 and on each three month anniversary thereafter. Pursuant to the Merger Agreement, the option vested in full immediately prior to the closing of the merger.
  • [F6]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $78,000.00, which represents the difference between $8.50 and the exercise price of the option per share.

Issuer

Astex Pharmaceuticals, Inc

CIK 0000919722

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000919722

Filing Metadata

Form type
4
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 7:33 PM ET
Size
10.8 KB